BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,190.00
+60.00 (1.17%)
At close: Apr 24, 2026
Market Cap518.29B +7.2%
Revenue (ttm)118.32B +15.1%
Net Income-87.50B
EPS-865.00
Shares Out101.03M
PE Ration/a
Forward PEn/a
Dividend200.00 (3.94%)
Ex-Dividend DateMar 30, 2026
Volume34,826
Average Volume66,143
Open5,130.00
Previous Close5,130.00
Day's Range5,090.00 - 5,190.00
52-Week Range4,435.00 - 6,320.00
Beta0.82
RSI51.09
Earnings DateMay 15, 2026

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements